1,4-dihydropyridine has been researched along with Autoimmune Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisenieks, E; Duburs, G; Ošiņa, K; Paramonova, N; Rostoka, E; Sjakste, N; Sjakste, T; Sokolovska, J | 1 |
| Gordon, TP; Jackson, MW; Waterman, SA | 1 |
2 other study(ies) available for 1,4-dihydropyridine and Autoimmune Diabetes
| Article | Year |
|---|---|
1,4-Dihydropyridine derivatives without Ca2+-antagonist activity up-regulate Psma6 mRNA expression in kidneys of intact and diabetic rats.
Topics: Animals; Diabetes Mellitus, Type 1; Dihydropyridines; Female; Humans; Kidney; Male; Proteasome Endopeptidase Complex; Rats; Up-Regulation | 2016 |
Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes.
Topics: Adult; Aged; Animals; Autoantibodies; Binding Sites; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Colon; Diabetes Mellitus, Type 1; Dihydropyridines; Female; Gastrointestinal Motility; Humans; Intestinal Diseases; Male; Mice; Middle Aged; Myoelectric Complex, Migrating; Vas Deferens | 2004 |